Could stem cells heal tough Crohn's fistulas? new trial aims to find out

NCT ID NCT06636032

Recruiting now Disease control Sponsor: University Hospital, Toulouse Source: ClinicalTrials.gov ↗

First seen Jan 05, 2026 · Last updated Apr 30, 2026 · Updated 18 times

Summary

This early-phase study tests a new stem cell treatment for people with Crohn's disease who have complex anal fistulas that haven't healed with standard care. The treatment uses donated fat-derived stem cells injected directly into the fistula to reduce inflammation and promote healing. The study will check for side effects and see if the fistulas close, both by physical exam and imaging. Only 9 participants will be enrolled to help determine the right dose and initial safety.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CROHN DISEASE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Toulouse Hospital
RECRUITING

Toulouse, France

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

CROHN DISEASE